日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia

定量 MYD88L265P 和 CXCR4S338X 分析用于评估华氏巨球蛋白血症临床试验的性能

Tsakmaklis, Nickolas; Hunter, Zachary R; Liu, Xia; Kofides, Amanda; Liu, Shirong; Guerrera, Maria Luisa; Guijosa, Alberto; Sun, Hao; Hatcher, John M; Peachey, Abigail; Patterson, Christopher J; Meid, Kirsten; Gustine, Joshua; Branagan, Andrew R; Sarosiek, Shayna R; Castillo, Jorge J; Treon, Steven P

Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia

1000 例华氏巨球蛋白血症患者的家族聚集性、临床特征、并发症和预后

Ramirez-Gamero, Andres; Tsakmaklis, Nicholas; Hunter, Zachary R; Guerrera, Maria Luisa; Guijosa, Alberto; Sarosiek, Shayna; Treon, Steven P; Castillo, Jorge J

Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia

将帕克替尼用于治疗MYD88突变型华氏巨球蛋白血症

Liu, Shirong; Kofides, Amanda; Liu, Xia; Hatcher, John M; Sun, Hao; Tsakmaklis, Nicholas; Guijosa, Alberto; Guerrera, Maria L; Pizzarella, Dominic; Peachey, Abigail L; Patterson, Christopher J; Hunter, Zachary R; Meid, Kirsten; Castillo, Jorge J; Sarosiek, Shayna R; Treon, Steven P

Single-cell RNA sequencing defines distinct disease subtypes and reveals hypo-responsiveness to interferon in asymptomatic Waldenstrom's Macroglobulinemia.

单细胞 RNA 测序定义了不同的疾病亚型,并揭示了无症状华氏巨球蛋白血症对干扰素的低反应性

Sklavenitis-Pistofidis Romanos, Konishi Yoshinobu, Heilpern-Mallory Daniel, Wu Ting, Tsakmaklis Nicholas, Aranha Michelle P, Hunter Zachary R, Ali Alaa K, Tsuji Junko, Haradhvala Nicholas J, Lightbody Elizabeth D, Towle Katherine, Hevenor Laura, Romee Rizwan, Briercheck Edward L, Smith Eric L, Liacos Christine-Ivy, Kastritis Efstathios, Dimopoulos Meletios A, Treon Steven P, Getz Gad, Ghobrial Irene M

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia

对既往接受过治疗的华氏巨球蛋白血症患者进行维奈托克单药治疗的长期随访

Castillo, Jorge J; Guijosa, Alberto; Allan, John N; Siddiqi, Tanya; Advani, Ranjana H; Flynn, Catherine A; Meid, Kirsten; Budano, Nina; Nguyen, Julia; Ramirez-Gamero, Andres; Tsakmaklis, Nicholas; Hunter, Zachary R; Patterson, Christopher J; Treon, Steven P; Sarosiek, Shayna

Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia

SARS-CoV-2加强疫苗在多发性骨髓瘤和华氏巨球蛋白血症患者中的免疫原性前瞻性研究

Branagan, Andrew R; Mo, Clifton; Lei, Matthew; Gustine, Joshua N; Yee, Andrew J; O'Donnell, Elizabeth; Castillo, Jorge J; Nadeem, Omar; Flynn, Catherine; Bernstein, Zachary; Nakamoto-Matsubara, Rie; Meid, Kirsten; Verma, Rakesh; Hunter, Zachary R; Guerrera, Maria L; Alter, Galit; Burke, Jill; Harrington, Cynthia; Agyemang, Emerentia; Gammon, Marilyn; Lively, Kathleen; Packer, Lisette; Horick, Nora; Laubach, Jacob; Mitsiades, Constantine S; Munshi, Nikhil; Anderson, Kenneth C; Treon, Steven P; Richardson, Paul G; Raje, Noopur S; Sarosiek, Shayna R

Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia

伊布替尼和维奈克拉作为有症状、初治华氏巨球蛋白血症的一线治疗

Castillo, Jorge J; Branagan, Andrew R; Sermer, David; Flynn, Catherine A; Meid, Kirsten; Little, Megan; Stockman, Katherine; White, Timothy; Canning, Alexa; Guerrera, Maria L; Kofides, Amanda; Liu, Shirong; Liu, Xia; Richardson, Kris; Tsakmaklis, Nicholas; Patterson, Christopher J; Hunter, Zachary R; Treon, Steven P; Sarosiek, Shayna

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

利用多组学方法鉴定MYD88突变型华氏巨球蛋白血症患者伊布替尼疗效的可靠预测因子

Richardson, Kris; Castillo, Jorge J; Sarosiek, Shayna R; Branagan, Andrew R; Flynn, Catherine A; Meid, Kirsten; Gustine, Joshua N; Liu, Xia; Kofides, Amanda; Liu, Shirong; Wolf, Julie L; Kacena, Katherine A; Patterson, Christopher J; Guerrera, Maria Luisa; Tsakmaklis, Nicholas; Treon, Steven P; Hunter, Zachary R

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings

一项针对COVID-19呼吸窘迫住院患者的BTK抑制剂zanubrutinib的随机、安慰剂对照试验:免疫生物标志物和临床结果

Treon, Steven P; Kotton, Camille N; Park, David J; Moranzoni, Giorgia; Lemvigh, Camilla K; Gathe, Joseph C Jr; Varughese, Tilly A; Barnett, Christopher F; Belenchia, Johnny M; Clark, Nina M; Farber, Charles M; Abid, Muhammad Bilal; Ahmed, Gulrayz; Patterson, Christopher J; Guerrera, Maria L; Soumerai, Jacob D; Chea, Vipheaviny A; Carulli, Isabel P; Southard, Jackson; Li, Shuqiang; Wu, Catherine J; Livak, Kenneth J; Holmgren, Eric; Kim, Pil; Shi, Carrie; Lin, Holly; Ramakrishnan, Vanitha; Ou, Ying; Olszewski, Scott; Olsen, Lars Rønn; Keskin, Derin B; Hunter, Zachary R; Tankersley, Christopher; Zimmerman, Todd; Dhakal, Binod

Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia

华氏巨球蛋白血症中先天性和适应性免疫肿瘤微环境的功能障碍

Cholujova, Danka; Beke, Gabor; Hunter, Zachary R; Hideshima, Teru; Flores, Ludmila; Zeleznikova, Tatiana; Harrachova, Denisa; Klucar, Lubos; Leiba, Merav; Drgona, Lubos; Treon, Steven P; Kastritis, Efstathios; Dorfman, David M; Anderson, Kenneth C; Jakubikova, Jana